Shan Kang
VMware (United States) · 9 works · 105 citations · h-index 6
Top works
- Intention‐to‐treat analysis with treatment discontinuation and missing data in clinical trials
- Missing not at random models for masked clinical trials with dropouts
- [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
- A Phase I/II trial design when response is unobserved in subjects with dose-limiting toxicity
- A Latent Variable Approach to Study Gene–Environment Interactions in the Presence of Multiple Correlated Exposures
- A semiparametric imputation approach for regression with censored covariate with application to an AMD progression study
- [Inhibitory effects of enhanced expression of CD40L in ovarian cancer OVHM cells on the liver metastases in mice].
- Treatment Effect Estimation for Randomized Clinical Trials Subject to Noncompliance and Missing Outcomes
- 5058 POSTER Randomized Phase II Multicenter Trial of Oral Antiangiogenic Agent TSU-68 in Combination With Docetaxel Versus Docetaxel Alone in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline